Premium
J apanese pediatric guideline for the treatment and management of bronchial asthma 2012
Author(s) -
Hamasaki Yuhei,
Kohno Yoichi,
Ebisawa Motohiro,
Kondo Naomi,
Nishima Sankei,
Nishimuta Toshiyuki,
Morikawa Akihiro,
Aihara Yukoh,
Akasawa Akira,
Adachi Yuichi,
Arakawa Hirokazu,
Ikebe Toshiichi,
Ichikawa Kunio,
Inoue Toshishige,
Iwata Tsutomu,
Urisu Atsuo,
Ohya Yukihiro,
Okada Kenji,
Odajima Hiroshi,
Katsunuma Toshio,
Kameda Makoto,
Kurihara Kazuyuki,
Sakamoto Tatsuo,
Shimojo Naoki,
Suehiro Yutaka,
Tokuyama Kenichi,
Nambu Mitsuhiko,
Fujisawa Takao,
Matsui Takehiko,
Matsubara Tomoyo,
Mayumi Mitsufumi,
Mochizuki Hiroyuki,
Yamaguchi Koichi,
Yoshihara Shigemi
Publication year - 2014
Publication title -
pediatrics international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.49
H-Index - 63
eISSN - 1442-200X
pISSN - 1328-8067
DOI - 10.1111/ped.12389
Subject(s) - medicine , guideline , asthma , exacerbation , pediatrics , disease , intensive care medicine , disease management , physical therapy , pathology , parkinson's disease
A new version of the J apanese pediatric guideline for the treatment and management of bronchial asthma was published in J apanese at the end of 2011. The guideline sets the pragmatic goal for clinicians treating childhood asthma as maintaining a “well‐controlled level” for an extended period in which the child patient can lead a trouble‐free daily life, not forgetting the ultimate goal of obtaining remission and/or cure. Important factors in the attainment of the pragmatic goal are: (i) appropriate use of anti‐inflammatory drugs; (ii) elimination of environmental risk factors; and (iii) educational and enlightening activities for the patient and caregivers regarding adequate asthma management in daily life. The well‐controlled level refers to a symptom‐free state in which no transient coughs, wheezing, dyspnea or other symptoms associated with bronchial asthma are present, even for a short period of time. As was the case in the previous versions of the guideline, asthmatic children younger than 2 years of age are defined as infantile asthma patients. Special attention is paid to these patients in the new guideline: they often have rapid exacerbation and easily present chronic asthmatic conditions after the disease is established.